• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dr. Marty Makary advances out of key committee in bid for FDA confirmation

by March 13, 2025
written by March 13, 2025

President Donald Trump’s nominee to lead the Food and Drug Administration (FDA), Dr. Marty Makary, passed a key committee vote 14-9 on Thursday morning, clearing the way for a full Senate vote on his nomination. 

If confirmed before the full Senate, Makary will work alongside the nominee for National Institute of Health (NIH) Director Dr. Jay Bhattacharya to achieve Secretary of Health and Human Services Robert F. Kennedy Jr.’s Make America Healthy Again agenda. 

The Senate Committee on Health, Education, Labor and Pensions(HELP) voted in favor of Makary’s confirmation following his committee hearing one week ago today. 

‘We now have a generational opportunity in American healthcare. President Trump and Secretary Kennedy’s focus on healthy foods has galvanized a grassroots movement in America. Childhood obesity is not a willpower problem, and the rise of early-onset Alzheimer’s is not a genetic cause. We should be, and we will, be addressing food as it impacts our health,’ Makary said last week. 

‘Thanks to the courage of President Trump and Secretary Kennedy, we now have a generational opportunity to usher in radical transparency to facilitate more cures, meaningful treatments and diagnostics at the FDA to help people take care of their own health,’ Makary added.

Makary was grilled by Democrats last week on vaccines, abortion, chronic illness and food safety. When repeatedly asked by Democratic senators on the committee whether he would revoke the approval process for Mifepristone, Makary said any decision on the abortion pill will come down to science. 

‘I have no preconceived plans on Mifepristone policy except to take a solid, hard look at the data and to meet with the professional career scientists who have reviewed the data at the FDA, and to build an expert coalition to review the ongoing data,’ he said. 

Makary, who advocated for natural immunity during the COVID-19 pandemic, flipped a question about vaccine processes around on Sen. Patty Murray, D-Wash., during his confirmation hearing, telling her to ask former President Joe Biden why he skipped a key step when it came to the COVID-19 booster. 

‘So, if you are confirmed, will you commit to immediately reschedule that FDA Vaccine Advisory Committee meeting to get the expert views?’ Sen. Patty Murray, D-Wash., asked Trump’s FDA pick. 

‘I would re-evaluate which topics deserve a convening of the advisory committee members on [Vaccines and Related Biological Products Advisory Committee] and which may not require a convening,’ Makary replied, adding that he was not a part of the decision. 

When asked again by Murray, he said: ‘Well, you can ask the Biden administration that chose not to convene the committee meeting for the COVID vaccine booster.’

He vowed during his committee hearing to lead his own Department of Government Efficiency (DOGE) investigations if confirmed. DOGE has terminated the employment of thousands of probationary HHS employees, including those at the FDA, since Trump took office. 

‘If confirmed, I will do my own independent assessment on personnel. I welcome input on efficiencies at the agency. At the same time, I want to make sure that the scientists and food inspectors and staff, central to the core mission of the agency, have all the resources they need to do their job well,’ Makary said last week. 

Makary has long been a critic of the FDA. He penned an opinion piece in 2021 that called for ‘fresh leadership at the FDA to change the culture at the agency and promote scientific advancement, not hinder it.’

Trump nominated Johns Hopkins School of Medicine professor, pancreatic surgeon and former Fox News medical contributor Dr. Marty Makary for FDA commissioner in November. 

‘I am very pleased to nominate Marty Makary MD, MPH, FACS, for FDA Commissioner,’ Trump said in a statement. ‘FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency.’ 

Trump said that Makary will ‘work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation’s food supply and drugs and biologics being given to our Nation’s youth, so that we can finally address the Childhood Chronic Disease Epidemic.’

Fox News Digital’s Julia Johnson contributed to this report.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
FDA chief counsel who defended abortion pill access under Biden resigns two days into job
next post
Trump’s pick for NIH director clears committee, heads to full Senate vote

related articles

TikTok isn’t enough to stop Gen Z from...

August 22, 2025

Trump administration wins Supreme Court fight to slash...

August 22, 2025

Zelenskyy seeks ‘strong reaction’ from US if Putin...

August 22, 2025

Pentagon unveils new medal for troops deployed in...

August 21, 2025

Federal judge rules Trump appointee Alina Habba is...

August 21, 2025

‘Maine’s Mamdani’: Maine GOP chief issues warning about...

August 21, 2025

‘There are 50 swamps’: State Freedom Caucus Network...

August 21, 2025

Trump-aligned legal group probes Biden-era organ transplant program...

August 21, 2025

NATO defense chiefs stress commitment to Ukraine, discuss...

August 21, 2025

Russian drone crashes in Polish field; Warsaw protests...

August 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • The first Fed interest rate cut in years is on the horizon. Here’s what you need to know.

    July 30, 2024
  • Oil continues to rise on Monday; natural gas has stabilized

    August 12, 2024
  • Harris concedes presidential race, campaign manager sends letter to staff: ‘Losing is unfathomably painful’

    November 6, 2024
  • Vance reveals ’empowering’ aspects of Trump’s leadership that enables ‘trust’ and squashes ‘turf battles’

    April 30, 2025
  • Canadian PM Justin Trudeau to announce resignation as early as Monday: report

    January 6, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,784)
  • Investing (634)
  • Stock (893)

Latest Posts

  • Ethereum, after a month, again above the $2700 level

    September 24, 2024
  • US Presidential Election: Harris, Trump & Debate

    August 1, 2024
  • Ford and Mazda issue do-not-drive warnings for 457,000 vehicles with Takata airbags

    August 13, 2024

Recent Posts

  • Former high-level United Nations officials to launch ‘DOGE-UN’ to highlight agency inefficiencies

    December 1, 2024
  • Massachusetts suspect charged with attempting to assassinate a Cabinet nominee

    May 10, 2025
  • RBC downgrades Moderna and cuts price target by 28%: Should you exit?

    August 5, 2024

Editor’s Pick

  • US military shoots down Houthi drones as Trump’s strikes against terrorist group continue

    March 17, 2025
  • Dems join clergy to pray for ‘moral reckoning’ to fix Big, Beautiful Bill: ‘I still know how to agitate’

    June 10, 2025
  • UAW union endorses Vice President Kamala Harris over Trump

    August 1, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock